DILATED CARDIOMYOPATHY

Clinical trials for DILATED CARDIOMYOPATHY explained in plain language.

Never miss a new study

Get alerted when new DILATED CARDIOMYOPATHY trials appear

Sign up with your email to follow new studies for DILATED CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 2 Not yet finished but already full! 4 Completed 9 Terminated 1

New heart drug AZD0233 begins first safety tests in healthy volunteers

Disease control Terminated

This early-stage trial tested the safety of a new drug called AZD0233 in 84 healthy adults aged 18 to 50. The drug is being developed for dilated cardiomyopathy, a condition where the heart becomes enlarged and weak. Participants received either the drug or a placebo, and researc…

Matched conditions: DILATED CARDIOMYOPATHY

Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Jun 27, 2026 08:14 UTC

DILATED CARDIOMYOPATHY

Get alerted when new DILATED CARDIOMYOPATHY trials appear

New heart drug AZD0233 begins first safety tests in healthy volunteers